PMC:7228307 / 42657-42875
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 725 | 143-158 | Chemical | denotes | N‐linked glycan |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T360 | 166-176 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T765 | 108-111 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T766 | 205-207 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T219 | 166-176 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T220 | 166-171 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T221 | 172-176 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T46 | 166-176 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 725 | 143-158 | Chemical | denotes | N‐linked glycan |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T240 | 0-85 | Sentence | denotes | At the time of writing, some mAbs with improved potency are coming into clinical use. |
| T241 | 86-218 | Sentence | denotes | Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4). |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T359 | 166-176 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T240 | 0-85 | Sentence | denotes | At the time of writing, some mAbs with improved potency are coming into clinical use. |
| T241 | 86-218 | Sentence | denotes | Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4). |